Disease and Therapy Review: Major Depressive Disorder

Disease and Therapy Review: Major Depressive Disorder

The Major Depressive Disorder Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatments, including SSRIs and atypical antidepressants, tricyclic antidepressants, monoamine oxidase inhibitors, and non-drug therapies. Dosing information and treatment costs are provided for a wide range of products. General information is included on the size of the US market for SSRIs.

Additional Information

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.

I. Overview
II. Incidence and Prevalence
Incidence Table: (Worldwide)
Prevalence Table: (US, Canada, UK, France, Germany, Spain, Japan, China, Mexico, Worldwide)
III. DIAGNOSIS
IV. TREATMENT
SSRIs and Atypical Antidepressants
Tricyclic Antidepressants
Monoamine Oxidase Inhibitors
Electroconvulsive Therapy
Phototherapy
Experimental Treatments
Psychological
Social
V. DOSING AND TREATMENT COSTS
VI MARKET SIZE
VII. COMMENTS
VIII. References/Resources